Research location
Webster
Texas, United States
Advertisement
Research activity in Webster
Texas, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 131 trials and 134 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Webster
131 linked trials · page 3 of 3Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary DiseaseNCT01124422 · 2010-07-19 · 1 site observation
COMPLETED
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes MellitusNCT01144338 · 2010-06-18 · 1 site observation
COMPLETED
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder CancerNCT01126749 · 2010-04-16 · 1 site observation
TERMINATED
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate CancerNCT00988208 · 2009-11-11 · 1 site observation
COMPLETED
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation
TERMINATED
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsNCT00909779 · 2009-06-01 · 1 site observation
COMPLETED
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536 · 2009-05-01 · 1 site observation
COMPLETED
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase InhibitorNCT00754325 · 2008-09-01 · 1 site observation
COMPLETED
Follow-Up Study for ExuberaNCT00734591 · 2008-08-01 · 1 site observation
COMPLETED
Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyNCT00676650 · 2008-07-01 · 1 site observation
TERMINATED
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast CancerNCT00593827 · 2008-05-01 · 1 site observation
COMPLETED
Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)NCT00661492 · 2008-05-01 · 1 site observation
COMPLETED
ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung CancerNCT00662597 · 2008-04-01 · 1 site observation
TERMINATED
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)NCT00571675 · 2007-10-01 · 1 site observation
COMPLETED
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line ChemotherapyNCT00547651 · 2007-09-01 · 1 site observation
COMPLETED
Adj TC + Herceptin Early Stage Breast CancerNCT00493649 · 2007-06-01 · 1 site observation
COMPLETED
TAC Versus TC for Adjuvant Breast CancerNCT00493870 · 2007-05-29 · 1 site observation
COMPLETED
Phase II Sunitinib Prog Met AIPCNCT00599313 · 2007-03-01 · 1 site observation
COMPLETED
Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior TherapyNCT00375193 · 2006-11-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior ChemotherapyNCT00364351 · 2006-08-01 · 1 site observation
COMPLETED
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular SafetyNCT00359801 · 2006-07-01 · 1 site observation
COMPLETED
Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.NCT00319969 · 2006-04-01 · 1 site observation
COMPLETED
Vidaza to Restore Hormone Thx ProstateNCT00384839 · 2006-04-01 · 1 site observation
COMPLETED
Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior ChemotherapyNCT00278993 · 2006-01-01 · 1 site observation
COMPLETED
Doxil & Carboplatin Plus HER2+ in Metastatic Breast CancerNCT00303108 · 2005-12-01 · 1 site observation
COMPLETED
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)NCT00087802 · 2004-03-01 · 1 site observation
COMPLETED
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy RegimenNCT00069745 · 2003-09-01 · 1 site observation
COMPLETED
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneNCT00036270 · 2001-08-01 · 1 site observation
COMPLETED
A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsNCT00085826 · 2001-04-01 · 1 site observation
COMPLETED
Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.